DB
OFIX icon

Dmitry Balyasny’s Orthofix Medical OFIX Stock Holding History

Dmitry Balyasny’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-28,055
Closed -$322K – 3366
2026
Q1 		$322K Buy
28,055
+12,330
+78% +$163K ﹤0.01% 2537
2025
Q4 		$238K Buy
+15,725
New +$240K ﹤0.01% 2825
2025
Q1 		– Sell
-38,623
Closed -$674K – 3155
2024
Q4 		$674K Buy
38,623
+22,471
+139% +$391K ﹤0.01% 2090
2024
Q3 		$252K Buy
16,152
+6,091
+61% +$97.6K ﹤0.01% 2500
2024
Q2 		$133K Buy
+10,061
New +$138K ﹤0.01% 2382
2018
Q3 		– Sell
-10,406
Closed -$591K – 1941
2018
Q2 		$591K Sell
10,406
-2,544
-20% -$145K ﹤0.01% 1295
2018
Q1 		$761K Buy
+12,950
New +$725K ﹤0.01% 1317

Other funds holding OFIX

ECM
Engine Capital Management New York $1.03B AUM 4.33% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Dmitry Balyasny's OFIX Position: Q2 2026 in Review

Dmitry Balyasny sold out of Orthofix Medical (OFIX) in Q2 2026, closing a stake of 28,055 shares — an estimated $322K sold.

Dmitry Balyasny first reported a position in OFIX in Q1 2018 and held it in 7 quarters. The position peaked at $761K in Q1 2018. 142 funds tracked by Wall St. Rank hold OFIX as of Q2 2026.

  • Dmitry Balyasny reported no remaining Orthofix Medical position as of Q2 2026 after selling out during the quarter.
  • Dmitry Balyasny sold 28,055 Orthofix Medical shares in Q2 2026, an estimated $322K.
  • Dmitry Balyasny first reported a position in Orthofix Medical in Q1 2018 and held it in 7 quarters.
  • Dmitry Balyasny's Orthofix Medical position peaked at $761K in Q1 2018.
  • 142 funds tracked by Wall St. Rank held Orthofix Medical as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.